Skip to content

Clinical trials

Triple Negative Breast Neoplasms trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Country / region: Spain Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20113
20124
20134
20142
20155
20169
201718
201811
201914
202017
20218
202212
20237
20249
20258
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Terminated28
Recruiting23
Active, not recruiting22
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals17
Hoffmann-La Roche8
Merck Sharp & Dohme LLC8
AbbVie7
Bristol-Myers Squibb5
Eli Lilly and Company5
AstraZeneca4
Gilead Sciences4
MedSIR4
Pfizer4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms133
Carcinoma, Non-Small-Cell Lung53
Breast Neoplasms33
Ovarian Neoplasms32
Squamous Cell Carcinoma of Head and Neck27
Melanoma23
Neoplasms23
Colorectal Neoplasms21
Carcinoma, Renal Cell18
Endometrial Neoplasms18

Trials

Showing 26 to 50 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.